A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Meta Platforms, Inc.'s technical signals, when combined with the TikTok situation, suggest a near-term consolidation. Learn ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

Doing a certain amount of exercise is linked to a 30% to 40% lower risk of an early death from any cause, according to a new ...

A massive meta-analysis shows staying active throughout adulthood can slash death risk by up to 40%. Learn why consistency matters more than perfection.

Pomegranate juice contains potent antioxidants that may help lower blood pressure, although finding are mixed. Learn why and ...

In recent years, the application of picosecond laser (PSL) treatment for skin discoloration caused by nevus of Ota has been ...

Ultimately, because authors introduced no evidence that Meta's AI threatened to dilute their markets, Chhabria ruled that ...

“Overall, this is high-quality research that strengthens the evidence base and promotes a more balanced and science-based understanding of antidepressant discontinuation. IIt reminds us that while ...

Digital health interventions (DHIs) show promise for the treatment of mental health disorders. However, existing ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

When encountering elderly ACS patients, clinical judgement is important given the risks of bleeding, says Arnold Seto.